What is the efficacy of Xgeva and Lupron in treating prostate cancer?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18128895
Cited by: 0

Abstract

Lupron and Xgeva are both effective in their respective roles in prostate cancer management: Lupron for androgen suppression and Xgeva for bone health during androgen deprivation therapy, though each carries specific adverse effect profiles.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Bone health and treatments Bone Metabolism and Diseases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
2 January 2026